Safety Reference · Last verified: May 8, 2026 · Next review: June 8, 2026
GLP-1 Pharmacy Label Red Flags: 18 Checks Before You Inject (2026)
By WPG Research Team · · Next review: June 8, 2026
The bottom line, up front
GLP-1 pharmacy label red flags fall into three buckets: stop now, verify before injecting, or document and watch. The eight that mean stop right now: a pharmacy you can't verify, no prescription required to buy, "semaglutide sodium" or "semaglutide acetate" as the active ingredient, "retatrutide" or "cagrilintide" listed in a compound, "for research use only" wording on something sold for human use, a known FDA-flagged counterfeit Ozempic lot, units-only dosing with no mg or mL, and "generic Ozempic/Wegovy/Zepbound" marketing. The full 18-flag breakdown — and exactly what to do at each tier — is below.
| Tier | What it means | What to do |
|---|---|---|
| 🛑 STOP | 8 red flags FDA has tied to fraud, illegal ingredients, or dangerous dosing | Do not inject. Verify and report if needed. |
| ⚠️ VERIFY | 7 label issues that aren't automatic fraud but need a phone call | Call the pharmacy before you use the vial. |
| 📋 DOCUMENT | 3 things that look weird but can be legitimate | Keep proof, ask questions, but don't panic. |
What Are GLP-1 Pharmacy Label Red Flags?
A GLP-1 pharmacy label red flag is anything on the label, packaging, or sale of a semaglutide or tirzepatide product that signals it might be fake, illegally compounded, dangerous to dose, or sold by a fraudulent pharmacy. The FDA has documented these red flags in seized counterfeits and warning letters. Some mean "do not inject." Others mean "make a phone call before you use it."
In search and patient language, "GLP-1" is the shorthand people use for GLP-1 receptor agonists and related incretin drugs: semaglutide, liraglutide, and orforglipron, plus tirzepatide, which is a dual GIP/GLP-1 receptor agonist. These are the active ingredients in Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza, and Foundayo.
The FDA's actual consumer guidance on this is short and vague. It tells people to "carefully check labels of compounded GLP-1 drugs for warning signs such as spelling errors or incorrect addresses." That's it. We built the operational version below.
The 18 GLP-1 Label Red Flags, Sorted by Severity
Read the row, run the check, take the action.
STOP — These 8 mean don't inject
| # | Red flag | Why it matters |
|---|---|---|
| 1 | The pharmacy on the label can't be verified anywhere | FDA has documented fraudulent compounded GLP-1 labels listing pharmacies that don't exist. Do not assume the address is real. |
| 2 | The pharmacy says it didn't make the product | FDA has also documented counterfeits using the names of real, licensed pharmacies that didn't actually compound the drug. Always call to confirm. |
| 3 | No prescription was required to buy it | The FDA and NABP flag any seller that ships GLP-1 without a prescription as illegal. NABP has reported that the vast majority of online pharmacies it reviews don't require valid prescriptions. |
| 4 | The label says "semaglutide sodium" or "semaglutide acetate" | These are salt forms of semaglutide. Per FDA, they are different active ingredients than the base form used in approved drugs, and the agency is not aware of a lawful basis for compounding with them. |
| 5 | The label says "retatrutide," "cagrilintide," or another GLP-1 not in an FDA-approved drug | FDA states these cannot be used in compounding under federal law. They are investigational. There is no "compounded retatrutide" sold legally for human use in the U.S. |
| 6 | The label says "for research purposes only" or "not for human consumption" but gives dosing instructions | FDA has issued multiple warning letters about products marketed this way as a legal shield while being sold for human use. |
| 7 | The lot number matches a known FDA counterfeit Ozempic alert | The current 2026-relevant lot numbers are NAR0074, PAR0362, and PAR1229. Specific identifying details in the section below. |
| 8 | It's marketed as "generic Ozempic," "generic Wegovy," "generic Mounjaro," or "generic Zepbound" | Per FDA, compounded drugs are not generics. There is no FDA-approved generic of any of these drugs as of May 2026. The marketing itself is the warning sign. |
VERIFY — These 7 need a phone call before you use it
| # | Red flag | Why it matters |
|---|---|---|
| 9 | Dosing is given only in "units" with no mg dose and no concentration | FDA documented patients administering 5 to 20 times the intended dose after confusion between units, mL, and mg. Full explanation in the units vs mg section below. |
| 10 | The concentration is different from your last vial (or your last provider) | FDA notes compounded semaglutide can come in different mg/mL concentrations. The same number of units can deliver a wildly different dose. |
| 11 | No lot number, no batch number, no compounded date | USP General Chapter <797> Section 13 calls for lot/batch and date information for traceability in case of a recall. A compound without it can't be traced. |
| 12 | No beyond-use date (BUD) on the label | A BUD (the date a compounded product stops being safe to use) is required under USP <797>. Without it, you have no idea when the product becomes unsafe. |
| 13 | No storage instructions, OR the package arrived warm or with melted ice packs | Injectable GLP-1 drugs require refrigeration as indicated in their package inserts or pharmacy storage instructions. FDA recommends not using any injectable GLP-1 drug that arrives warm or with insufficient refrigeration. |
| 14 | Spelling errors, wrong address, or odd typography on the label | FDA's specific consumer guidance flags this. A licensed pharmacy generally doesn't misspell its own name. |
| 15 | Semaglutide is combined with other ingredients (like B12) without a clear clinical reason | FDA says the safety and effectiveness of combining semaglutide with other ingredients has not been established. FDA's April 2026 compounding policy clarification notes that semaglutide-plus-B12 may still be treated as essentially a copy depending on route, strength, and other facts. |
DOCUMENT — These 3 look weird but aren't automatic fraud
| # | Looks weird | Why it can be legitimate |
|---|---|---|
| 16 | Compounded GLP-1 in a vial (not a pen) | Compounded semaglutide and tirzepatide are typically dispensed in vials. A pen labeled with a brand name like "Ozempic" but described as compounded is a red flag — but a vial alone is not. |
| 17 | The label says "compounded" | This is required by USP General Chapter <7> when the drug is actually compounded. It's a sign the pharmacy is following rules, not breaking them. |
| 18 | A BUD shorter than a year | This is normal for compounded sterile preparations. Typical BUDs run 28 to 120 days, and a pharmacy without product-specific stability data is supposed to use the shorter end. |
The goal of this list isn't to scare you. It's to give you a source-backed red-flag triage built from FDA, USP, DailyMed, NABP, CDC, and state-board rules.
Wait — Is My GLP-1 in a Vial Automatically a Red Flag?
Brand-name GLP-1 format check (verified )
| If the product label says… | Comes legitimately as… | If you see it in a vial… |
|---|---|---|
| Ozempic (Novo Nordisk) | Prefilled injection pens only | 🛑 STOP — Ozempic is not sold in vials. A vial labeled "Ozempic" is not authentic Novo Nordisk Ozempic. |
| Wegovy (Novo Nordisk) | Injection pens and oral tablets | 🛑 STOP — Wegovy is not sold in vials. A vial labeled "Wegovy" is not authentic. |
| Rybelsus (Novo Nordisk) | Oral tablets only | 🛑 STOP — Rybelsus is a pill, not an injection. A vial labeled "Rybelsus" is not authentic. |
| Mounjaro (Eli Lilly) | KwikPens, single-dose pens, single-dose vials, and multi-dose vials | ⚠️ VERIFY — Lilly does sell Mounjaro in vials. Confirm the format matches Lilly's official presentation per DailyMed. |
| Zepbound (Eli Lilly) | KwikPens, single-dose pens, single-dose vials, and multi-dose vials | ⚠️ VERIFY — Same as Mounjaro. Vials can be authentic. Verify packaging matches DailyMed. |
| Compounded semaglutide | Compounded vials (and sometimes oral troches) | 📋 DOCUMENT — Vials are the standard format. Verify the rest of the label. |
| Compounded tirzepatide | Compounded vials (and sometimes oral troches) | 📋 DOCUMENT — Same as above. Verify the rest of the label. |
The reason competitor pages get this wrong: they read "Ozempic in a vial = fake" and apply it to all GLP-1s. That's not how it works. Eli Lilly's KwikPen and vial presentations are both legitimate per their DailyMed labeling. Compounded GLP-1s are typically sold in vials by design. The format isn't the test — the brand-name match and the pharmacy verification are.
What Every Legitimate Compounded GLP-1 Label Should Let You Verify
Below is a 12-item verification checklist, not a single national label law. 503B outsourcing facilities (large-batch compounders registered with FDA) have specific federal label requirements. 503A patient-specific prescription labels are governed by state prescription-label rules, USP standards, and pharmacy-practice requirements. For a GLP-1 injection, the label and pharmacy record should let you verify every item below.
| # | Verification element | What it should look like | Source |
|---|---|---|---|
| 1 | Active ingredient + concentration in mg/mL | "Semaglutide 2.5 mg/mL" or "Tirzepatide 10 mg/mL" | USP <7> §A.5; USP <797> §13 |
| 2 | Pharmacy name + full street address + phone | A real, verifiable U.S. pharmacy with a working phone | USP <7>; state Rx law |
| 3 | Pharmacy license status you can verify externally | Active or current license in the state-board database; license number may appear on label or lookup record | State board lookup / FDA BeSafeRx |
| 4 | Patient name or dispensing record | Your name on a 503A patient-specific prescription; 503B labels may look different, but the dispensing pharmacy should tie the product to your prescription | State Rx law / pharmacy record verification |
| 5 | Prescriber name | A real, verifiable prescriber (NPI verifiable on the NPPES Registry) | Federal/state Rx law |
| 6 | Beyond-use date (BUD) | Specific calendar date the product becomes unsafe to use | USP <797> §14 |
| 7 | Lot or batch number | Alphanumeric ID for traceability and recall | USP <797> §13 |
| 8 | Storage instructions | Refrigeration range and any light/freezing protections per the pharmacy's stability data | USP <797> §13 |
| 9 | Route of administration | "For subcutaneous injection only" | USP <7> §A.5 |
| 10 | The word "compounded" | "Compounded Semaglutide Injection" or similar | USP <7> Labeling for Compounded Preparations |
| 11 | Dose clarity in mg, mL, and syringe units (if a syringe is used) | "Inject 0.25 mL (0.5 mg) once weekly" plus the matching syringe-unit instruction | FDA dosing-error guidance / safety verification |
| 12 | A working pharmacy phone number for questions | A real line that connects to a pharmacist | State Rx law |
How to Verify Your Pharmacy in 5 Minutes
This is the single most useful action on the entire page. If your pharmacy passes a state-board check and confirms your prescription on a phone call, most label concerns resolve themselves.
Look up the pharmacy on the state board (60 seconds)
Every state has a free online lookup tool. Search "[state name] board of pharmacy license verification." Examples:
- Texas: pharmacy.texas.gov/dbsearch
- California: pharmacy.ca.gov (License Verification)
- North Carolina: portal.ncbop.org/verification
- Florida: mqa-internet.doh.state.fl.us/MQASearchServices
The result should show: status "Active" or "Current," a license expiration date in the future, and the same address you see on your label. If it returns nothing, or returns a different address, that's a stop-and-don't-inject signal.
Cross-check with NABP and FDA tools (60 seconds)
- NABP Safe Pharmacy (safe.pharmacy/buy-safely): runs an audit of online pharmacies. If your seller is on the "not recommended" list, stop.
- FDA BeSafeRx (fda.gov/drugs/besaferx): the FDA's consumer tool for checking online pharmacies. Includes a directory of state-board lookups.
- FDA registered outsourcing facilities list (fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities): if the label says it was made by a 503B outsourcing facility, the facility should appear here.
Check the prescriber on NPPES (30 seconds)
Go to npiregistry.cms.hhs.gov, type the prescriber's name. Confirm specialty, state, and that the NPI exists. If the prescriber doesn't show up after searching the exact name and state — or the specialty and state are completely wrong — call the pharmacy and prescriber to verify before injecting.
Call the pharmacy on the label — using a number you found independently (3 minutes)
This is the most important step. The phone number on a fake label often connects to the same fake operation. Look up the pharmacy's number from the state board database (not the label) and call it.
"Hi, I'm a patient verifying a compounded prescription. I received a vial labeled as compounded by your pharmacy with prescription number [number] and lot number [lot]. Can you confirm you filled this for me, the active ingredient, the concentration in mg/mL, the BUD, and the storage instructions?"
A legitimate pharmacy should pull up the record or explain exactly why it can't. If the line dead-ends, the pharmacy has no record, or the label points to a pharmacy that denies filling it — that's the red flag.
Cross-check the brand-name product on DailyMed (if applicable)
If your label says "Ozempic," "Wegovy," "Mounjaro," "Zepbound," "Rybelsus," or any other brand name, look up the official product on DailyMed (dailymed.nlm.nih.gov). DailyMed is the National Library of Medicine's official FDA labeling repository. Compare:
- Active ingredient name
- Strength
- Form (pen vs vial vs tablet)
- Carton appearance
If your product doesn't match the official DailyMed entry, it isn't authentic.
The "Units vs mg" Trap That Put People in the Hospital
mg
How much medicine
mL
How much liquid (volume)
mg/mL
The concentration (how much medicine per unit of volume)
"units" on a 1 mL insulin syringe
Volume markings, where 100 units = 1 mL
Here's the trap:
A label that says "inject 5 units once a week" tells you nothing on its own. Five units of what concentration? If the vial is 2.5 mg/mL, 5 units is 0.05 mL, which delivers 0.125 mg. If the vial is 5 mg/mL, the same 5 units delivers 0.25 mg — double. And if a patient looks at "5 units" and accidentally draws to the 50-unit line on the syringe, they get ten times the intended dose.
This actually happens — FDA Drug Safety Communication case examples (Utah Poison Control documented):
Patient drew 50 units instead of 5. The vial was not labeled with a concentration. Patient experienced nausea and vomiting.
Patient injected 1 mL instead of 0.1 mL. Vomiting, headache, weakness, fatigue. The pharmacy had not provided dosing counseling.
An aesthetic spa administered an injection labeled as semaglutide; patient developed nausea, vomiting, and abdominal pain.
The common thread: the patient or clinician did not have a clear mg-to-mL-to-units path before the injection happened. That's the label failure this page is trying to catch.
The Current FDA Counterfeit Ozempic Lot Numbers
If your product label says "Ozempic," check it against these three FDA-issued counterfeit alerts. Each is a confirmed FDA seizure with public visual identification details.
| FDA alert date | Lot number | Identifying details | What to do |
|---|---|---|---|
| December 21, 2023 | NAR0074 | Serial number 430834149057. FDA found counterfeit pen labels, cartons, patient/provider information, and counterfeit needles whose sterility couldn't be confirmed. | Do not use, sell, or distribute. Report to FDA MedWatch. |
| April 14, 2025 | PAR0362 | Authentic lot number, but the serial numbers starting with 51746517 are counterfeit. Counterfeit pen label, accompanying information, and carton. | Do not use, sell, or distribute. Report to FDA MedWatch. |
| December 5, 2025 | PAR1229 | The visual tell is the placement of the EXP/LOT text. On counterfeit PAR1229, the EXP/LOT text appears on the left side of the expiration date and lot number. On authentic Ozempic, EXP/LOT text appears above them. | Do not use unless you received it through the Novo Nordisk Patient Assistance Program — those are authentic. |
The Arkansas State Board of Pharmacy verified a suspect Ozempic product using NABP's Pulse Product Verification Service in January 2025. In February 2025, the Arkansas board suspended the distributor's license after counterfeit Ozempic reached an Arkansas pharmacy. The detection technology exists. The system works — but only if you check.
A 2024 peer-reviewed study published in JAMA Network Open (Ashraf et al.) tested no-prescription online semaglutide vendors. Lab analysis found purity of 7% to 14% versus the 99% claimed online, and measured semaglutide content was 29% to 39% higher than labeled. Vendors used payment methods including Zelle, Bitcoin, and CashApp. If a vendor asks for crypto, peer-to-peer payments, or extra customs charges, those are confirmed JAMA-documented scam patterns.
How to Read a Beyond-Use Date Without Over-Reading It
The beyond-use date (BUD) is one of the most misunderstood numbers on the label. The BUD depends on USP category, compounding method, sterility testing, storage, container, and stability data. There isn't a single "right" range. Use this as a triage tool, not a compliance ruling.
| Your BUD situation | What it means | Concern level |
|---|---|---|
| Already passed | Don't use it | High |
| No BUD or expiration date anywhere | You cannot tell the stop date from the label | High |
| BUD is more than 28 days after first puncture, and the vial is opened | Multi-dose vials are generally discarded within 28 days after first puncture per CDC injection-safety guidance, unless the pharmacy gives a different validated opened-vial date | Verify |
| BUD is longer than 180 days from compounding | Ask what stability and sterility data supports it; this can exceed USP <797> Category 3 limits depending on process and storage | High concern |
| BUD is present, storage is clear, and the pharmacy can confirm it | This is the label doing its job | Document |
For more on safe storage — including refrigeration rules for each major GLP-1 brand, travel tips, and dorm-specific guidance — see our GLP-1 medication storage temperature guide.
What Is NOT Proof Your GLP-1 Is Safe
This section is here because every other "fake GLP-1" page online stops at the obvious red flags. People get fooled by things that look like proof but aren't.
| Looks like proof | Why it's not | What actually helps verify it |
|---|---|---|
| A clean, professional-looking label | Fraudulent compounded GLP-1s FDA seized had professional-looking labels. JAMA Network Open (Ashraf et al., 2024) found three no-prescription semaglutide samples had purity of 7%–14% versus 99% claimed, with drug content 29%–39% higher than labeled. The label looked fine. The contents weren't. | A pharmacy verifiable on the state board database |
| A telehealth brand name on the box | The telehealth brand and the dispensing pharmacy are usually different entities. The telehealth brand is a marketing wrapper. The pharmacy is the actual maker. | The dispensing pharmacy disclosed by name and verified on the state board |
| A Certificate of Analysis (CoA) screenshot | A CoA can be useful evidence, but it can also be forged or apply to a different batch. A CoA without pharmacy verification is just a PDF. | A CoA whose batch number matches the batch on your label, combined with state-board pharmacy verification, prescription verification, dose clarity, BUD, storage, and lot/batch traceability |
| A low price | Cheap is often the bait, not the proof. In the JAMA Network Open no-prescription semaglutide study, vendors used Zelle, Bitcoin, CashApp, and crypto, and nondelivery scams demanded $650–$1,200 in fake customs fees. | Price only helps when the pharmacy, prescription, label, and payment path also check out |
| A doctor's name on a website | Anyone can list "Dr. Smith, Medical Director" on a homepage. NPI lookup takes 30 seconds. | Prescriber verifiable on the NPPES NPI Registry |
| A PCAB accreditation logo on a website | The Pharmacy Compounding Accreditation Board (PCAB) is a real and useful accreditation, but the logo can be displayed without accreditation. Verify on achc.org. | PCAB accreditation confirmed in the ACHC directory |
| "FDA registered" claims | "FDA registered" doesn't mean "FDA inspected" or "FDA approved." Per a Partnership for Safe Medicines analysis, of the 48 newly-registered 503B outsourcing facilities since June 2021, 81% had never been inspected by FDA staff as of mid-2025. | Specific verifiable registration status on FDA's registered outsourcing facilities list, plus inspection or compliance records where available |
If a seller can't pass these tests in five minutes, that itself is the answer.
What if My GLP-1 Package Arrived Warm or the Ice Packs Melted?
- 1Don't put the vial in the fridge and pretend it's fine. That doesn't reverse degradation.
- 2Photograph the packaging, ice packs, and any temperature indicator Time-stamped photos before you touch anything.
- 3Call the pharmacy. Ask whether the product was shipped with a temperature monitor, what the validated storage range is, and whether they will replace the shipment.
- 4A reputable pharmacy will replace it. A pharmacy that pushes back on a documented warm shipment is itself a red flag.
Is Compounded Semaglutide With B12 a Red Flag?
Some 503A pharmacies use the B12 addition as a "clinical differentiation" so they can keep compounding semaglutide after FDA's shortage resolution. Some patients genuinely benefit from B12 supplementation. The fact that B12 is on the label doesn't tell you which one applies.
What to ask the prescriber and pharmacy:
- Why was B12 added? Is there a documented clinical reason for me — not a generic marketing one?
- What dose of B12 am I getting per injection? It should be on the label or in the dispensing record.
- Is this product compliant with FDA's April 2026 guidance on combined-ingredient compounding? Pharmacies operating in good faith should be able to answer.
If the answer to "why B12" is "everybody gets it" or "it makes the formulation legal," that's a regulatory shortcut, not a clinical one. We'd flag that and verify before continuing.
You Found a Red Flag — Here's Exactly What to Do
If you've been reading this page with a vial in your hand and you've spotted a problem, here's the operational sequence. The right answer depends on whether you've already injected.
Path 1: You haven't injected yet
- 1Don't inject. Set the vial aside in the refrigerator (do not throw it away yet).
- 2Photograph everything. Front and back of the label, the carton, the packing slip, the shipping label, and prescription paperwork. Time-stamped photos.
- 3Cross-check the pharmacy using the 5-minute verification above (state board, FDA, NABP, NPPES).
- 4Call the pharmacy using an independently-found number. Confirm it filled your prescription with this specific lot.
- 5If the pharmacy denies it or can't be reached: stop here. Treat as fraud.
- 6Call your prescribing provider or telehealth clinic. Tell them what you got. Ask them to verify with the pharmacy and arrange a replacement.
- 7File an FDA MedWatch report if you believe the product is counterfeit or unsafe. Online: accessdata.fda.gov/scripts/medwatch. Phone: 1-800-FDA-1088 (1-800-332-1088).
- 8Request a full refund or verified replacement. Don't accept a replacement from the same source if you can't verify them.
Path 2: You've already injected
Get medical care now if you have any of:
- Severe nausea, vomiting, or dehydration that won't stop
- Severe abdominal pain
- Spreading redness, swelling, fever, or pus at the injection site (signs of infection)
- Sweating, shaking, confusion, fainting (signs of severe hypoglycemia)
For severe symptoms, call 911 or go to the emergency room.
- 1Possible overdose, person awake and stable: Call Poison Control at 1-800-222-1222. Free, expert-staffed, confidential. Also at poison.org.
- 2No symptoms but concerned: Call your prescribing provider and primary care provider today. Tell them exactly what you injected, when, and why you're worried about the label.
- 3Don't throw away the product or packaging. It may be needed for testing, FDA reporting, or your clinical follow-up.
- 4Stop using the product. Do not inject another dose, even from the same vial.
- 5File an FDA MedWatch report at accessdata.fda.gov/scripts/medwatch or 1-800-FDA-1088. This is how FDA identifies emerging counterfeit clusters.
FDA's public alerts show that some suspect-product reports had no serious adverse events tied to the specific counterfeit product, but compounded GLP-1 dosing errors have sent some patients for medical care or hospitalization. The data only exists because patients reported what they saw.
How Do I Report a Suspected Fake GLP-1 Medication?
Report suspected counterfeit GLP-1 medication, product-quality problems, product-use errors, and serious adverse events to FDA MedWatch — the agency's official reporting system.
Online
accessdata.fda.gov/scripts/medwatch
By phone
1-800-FDA-1088 (1-800-332-1088)
Mail/fax
Download Form FDA 3500 from MedWatch site. Fax to 1-800-FDA-0178.
For pharmacy-license problems
Also report to the state board of pharmacy where the pharmacy is located AND where you received the medication. NABP maintains a directory at nabp.pharmacy/about/boards-of-pharmacy.
What to have ready when you report:
You don't need to be certain the product is fake to file. MedWatch reports help FDA identify patterns — including the patterns that led to the December 2023, April 2025, and December 2025 counterfeit Ozempic seizures.
When Is Compounded GLP-1 Actually OK to Use?
Compounded semaglutide and tirzepatide are not categorically unsafe. The compounding pathway exists for legitimate medical reasons, and many compounded GLP-1s come from licensed, accredited, careful pharmacies.
A compounded GLP-1 is most likely legitimate when all of these are true:
- The dispensing pharmacy is named, licensed, and verifiable on the state board of pharmacy database where it operates
- You received a prescription from a licensed prescriber after an actual clinical evaluation (not a 30-second form)
- The active ingredient is "semaglutide" or "tirzepatide" — the base form, not "semaglutide sodium" or "semaglutide acetate"
- The label contains all 12 verification elements (see our table earlier)
- The dosing instructions include both mg AND mL, not just units
- Storage instructions are present, the package arrived cold, and any cold-chain monitoring confirms it stayed cold
- If the pharmacy provides a Certificate of Analysis, the batch number on the CoA matches the batch number on your label
- The payment path is normal for a licensed medical/pharmacy transaction (no crypto, peer-to-peer, wire transfers, or surprise customs fees)
- The pharmacy answers the phone, the prescriber is real, and both can confirm your prescription
What compounded GLP-1s are not:
- Not generic drugs. There is no FDA-approved generic of Ozempic, Wegovy, Mounjaro, or Zepbound as of May 2026. "Generic Ozempic" doesn't exist.
- Not FDA-approved. Compounded medications don't go through FDA's safety, efficacy, or quality review.
- Not all the same. A PCAB-accredited 503A pharmacy with rigorous stability testing is a different animal than a back-of-a-spa operation with a three-page website.
The point isn't that compounded means bad. It's that compounded means you have to do verification work that a brand-name product would do for you.
If you're evaluating telehealth providers and want to know which ones use PCAB-accredited pharmacies and transparent dispensing disclosure, see our GLP-1 telehealth safety checklist.
Frequently Asked Questions
What We Actually Verified for This Page
We built this page from primary or authoritative sources. Peer-reviewed, accreditation, industry, and consumer-safety sources are labeled where used.
Primary regulatory sources
- ·FDA — FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
- ·FDA — Counterfeit Ozempic alerts (December 21, 2023; April 14, 2025; December 5, 2025)
- ·FDA — Drug Safety Communication on dosing errors with compounded injectable semaglutide
- ·FDA — Registered Outsourcing Facilities list
- ·FDA — BeSafeRx consumer pharmacy verification program
- ·FDA — April 2026 compounding policy clarification (semaglutide and tirzepatide)
- ·FDA — September 2025 warning letters to telehealth GLP-1 sellers
- ·FDA — March 2026 enforcement actions against telehealth companies
- ·DailyMed — product labels for Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus
- ·USP General Chapter <797> §13 (Labeling) and §14 (Beyond-Use Dates)
- ·USP General Chapter <7> Labeling (September 1, 2023)
- ·USP General Chapter <795> Pharmaceutical Compounding — Nonsterile Preparations
- ·CDC injection safety guidance for multi-dose vials
Authoritative non-regulatory sources
- ·National Association of Boards of Pharmacy — consumer guidance and Safe Pharmacy directory
- ·Pharmacy Compounding Accreditation Board / ACHC — accreditation directory
- ·JAMA Network Open — Ashraf et al., "Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases" (2024)
- ·American Journal of Managed Care — review of compounded semaglutide, including Utah Poison Control case series
- ·National Consumers League — September 2025 report on compounded GLP-1 fraud
- ·Partnership for Safe Medicines — analysis of 503B inspection rates
- ·State boards of pharmacy — license verification examples (Texas, North Carolina, California, Florida)
Related pages on this site
This page does not provide medical, legal, or financial advice. It is a consumer-facing synthesis of FDA, USP, DailyMed, NABP, CDC, and pharmacy-law guidance as it applies to compounded and brand-name GLP-1 labels. Always consult your prescribing provider about specific medications and doses. If you believe you are having a medical emergency, call 911. For possible poisoning or dosing errors, call Poison Control at 1-800-222-1222.